Picture of IGC Pharma logo

IGC — IGC Pharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapMomentum Trap

Brief: IGC Says FDA Approves Initiation Of Co's Cannabinoid Trial On Alzheimer's Patients

Aug 11 (Reuters) - India Globalization Capital Inc  IGC.A :
    * FDA APPROVES INITIATION OF IGC’S CANNABINOID TRIAL ON
ALZHEIMER’S PATIENTS
    * INDIA GLOBALIZATION CAPITAL INC - ANNOUNCES FDA REMOVAL OF
CLINICAL HOLD FOR MULTIPLE ASCENDING DOSE STUDY OF IGC-AD1

Source text for Eikon:  ID:nBw29kLjLa 
Further company coverage:  IGC.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on IGC Pharma

See all news